Highlights {#Sec1}
==========

1\. There was an association between *ENAM* rs3796704 polymorphism and the risk of dental caries.

2\. There was no association between polymorphisms of *LTF* (rs1126478), *ENAM* (rs1264848 and rs3796703), and *AMELX* (rs946252, rs17878486, and rs2106416) and dental caries susceptibility.

Introduction {#Sec2}
============

Dental caries can significantly affect the general health and quality of life in the modern world \[[@CR1]\]. Dental caries develops following demineralization of tooth structure and often results in pulpal and periapical inflammation, and subsequent pain, infection and tooth loss \[[@CR1], [@CR2]\]. Some environmental conditions and population groups may contribute to higher incidence of dental caries \[[@CR2]\]. Environmental risk factors may also affect dental caries development \[[@CR3]\]. Although exposed to the same environmental conditions, some patients may be more sensitive or more resistant to dental caries than others; such differences may be due to genetic factors in dental caries etiopathogenesis \[[@CR4]\]. New findings raised possibilities of presence of associations between genetic factors and dental caries \[[@CR5]\]. The etiology of dental caries involves complex interactions between genetic and environmental factors. Three prevalent genes are reportedly involved in development of dental caries namely the *lactotransferrin (LTF)*, *enamelin (ENAM)*, and *amelogenin X (AMELX)*. The rs1126478 polymorphism of *LTF* (a saliva protein gene) produces a shift from arginine to lysine at amino acid position 47 in the antimicrobial region, and presents transcriptional activation activity \[[@CR6]\]. *LTF* can decrease the lipopolysaccharide-activated innate immune response, regulate the adaptive immune system \[[@CR7]\], and play a significant role in physiological homoeostasis, which is in turn related to disease development \[[@CR8]\]. *ENAM* (a member of P/Q-rich secretory calcium-binding phosphoprotein cluster genes) is located on chromosome 4q 13.3 \[[@CR9]\]. The gene encodes the protein enamelin, which is the largest protein found in the enamel matrix and is involved in dental enamel mineralization and its structural organization \[[@CR10]\]. *AMELX* is an essential gene that produces amelogenin as the main protein of dental enamel during the secretion stage of amelogenesis \[[@CR11]\]. *AMELX* polymorphisms result in distinct alternations in enamel microstructure \[[@CR12]\]. Therefore, these polymorphisms play a critical role in regulation of mineralization and enamel thickness \[[@CR13]\]. The association between the mutations of *LTF*, *ENAM*, and *AMELX* genes and dental caries susceptibility has been shown in some studies \[[@CR5], [@CR14], [@CR15]\]. Therefore, we aimed to assess the association of polymorphisms of these genes and the risk of dental caries in a meta-analysis of case-control studies and therefore evaluating only the genetic influences for dental caries.

Materials and methods {#Sec3}
=====================

Search strategy and study selection {#Sec4}
-----------------------------------

One author systematically searched the PubMed/Medline, Web of Science, Cochrane Library, and Scopus databases to retrieve articles published by October 2019 without publication period, language, and patient's age restrictions. The search terms or keywords were ("lactotransferrin" or "lactoferrin" or "LTF" or "enamelin" or "ENAM" or "amelogenin X" or "AMELX") and ("dental caries" or "caries" or "decay") and ("gene" or "polymorphism" or "variant" or "genetic"). In addition, the references of the retrieved articles related to the topic including original and review articles were searched to make sure that no study was missed. After article retrieval, another author assessed the titles and abstracts of the articles related to the topic; subsequently, the full-texts of the articles that met our eligibility criteria were downloaded and screened. After screening, the exclusion reason was recorded for any study removed, and the disagreements between the authors were resolved by another author.

Eligibility criteria {#Sec5}
--------------------

The inclusion criteria were as follows: (I) studies including two independent groups (case group with caries or high caries and caries-free control group or with low/very low caries) without age restriction, (II) studies with any defined Decayed, Missing, and Filled Teeth (DMFT) score for the two groups, (III) studies including one or more polymorphisms of *LTF*, *ENAM*, and *AMELX* genes with a minimum of two relevant studies for the analysis; for example, four studies assessed *LTF* rs1126478, *ENAM* rs1264848, *ENAM* rs3796704, *ENAM* rs3796703, *AMELX* rs946252, *AMELX* rs17878486, *AMELX* rs6639060, and *AMELX* rs2106416 polymorphisms; and (IV) patients and controls had to have no genetic diseases, chronic illnesses, or other disorders. We excluded irrelevant studies, studies without sufficient data for analysis, studies without a control group, studies including less than 20 individuals in each group, duplicate studies, animal studies, case reports, conference papers, reviews, and systematic reviews.

Data abstraction {#Sec6}
----------------

Two authors independently abstracted the data of the studies analyzed in the meta-analysis. The data from each study, including first author, publication year, country of residence of the included individuals, ethnicity, mean age of individuals in the two groups, age group of individuals in each study, genotyping method, DMFT score of the two groups, and type of reported polymorphism (s) in each study, were extracted and analyzed.

Statistical analysis {#Sec7}
--------------------

Review Manager 5.3 (RevMan 5.3) software was applied to compute the odds ratios (ORs) and 95% confidence intervals (CIs). To estimate the significance of the pooled OR by the Z test, a *p*-value (two-sided) \< 0.05 was considered significant. The I^2^ statistic was used to estimate heterogeneity. A *p* \< 0.1 or I^2^ \> 50% indicated a significant heterogeneity and we used the random-effects model for such cases; if not, the fixed-effects model was used. The publication bias across the studies was assessed using the Egger's and Begg's tests. If *p* \< 0.05 (two-sided) for both tests or one, there was a significant degree of publication bias. In order to evaluate the stability/consistency of the results, the sensitivity analysis with both "the removal of one study" and "cumulative analysis" was performed. The results of these tests were retrieved by Comprehensive Meta-Analysis 2.0 (CMA 2.0) software. All authors revised the extracted data and the analyses and the disagreement between them was resolved by a discussion.

Results {#Sec8}
=======

Study selection {#Sec9}
---------------

A total of 150 records were identified in the databases; after removing the duplicates and irrelevant records, 29 full-text articles were evaluated for eligibility (Fig. [1](#Fig1){ref-type="fig"}). Next, 13 articles were excluded with reasons: two studies were systematic reviews, two studies were reviews, three studies lacked sufficient data, two studies had no control group, three studies did not report any of the mentioned polymorphisms in this meta-analysis and did not have any known polymorphism either, and one study reported rs1126478 polymorphism with less than 20 individuals in each group. Finally, 16 studies were entered into the analysis. Fig. 1Flow chart of study selection

Study characteristics {#Sec10}
---------------------

The characteristics of 16 studies included in this meta-analysis are presented in Table [1](#Tab1){ref-type="table"}. The articles had been published from 2008 to 2019. Eleven studies had been conducted on Caucasians \[[@CR12], [@CR14]--[@CR16], [@CR18]--[@CR23], [@CR25]\], four studies had been conducted on Asians \[[@CR5], [@CR13], [@CR17], [@CR24]\], and one on mixed \[[@CR11]\] ethnicities. Eleven studies evaluated children \[[@CR5], [@CR11], [@CR13]--[@CR16], [@CR18]--[@CR20], [@CR22], [@CR24]\], three studies evaluated adults \[[@CR17], [@CR21], [@CR23]\], and two studies evaluated both adults and children \[[@CR12], [@CR25]\]. Four studies had assessed *LTF* rs1126478 in 1556 cases and 1106 controls \[[@CR5], [@CR16], [@CR20], [@CR24]\]. Five studies had assessed *ENAM* rs1264848 in 934 cases and 600 controls \[[@CR11], [@CR14], [@CR19], [@CR22], [@CR25]\]. Four studies had assessed *ENAM* rs3796704 in 574 cases and 533 controls \[[@CR11], [@CR19], [@CR23], [@CR25]\]. Two studies had assessed *ENAM* rs3796703 in 585 cases and 567 controls \[[@CR5], [@CR13]\]. Three studies had assessed *AMELX* rs946252 in 151 cases and 147 controls \[[@CR11], [@CR12], [@CR19]\]. Four studies had assessed *AMELX* rs17878486 in 249 cases and 193 controls \[[@CR11], [@CR15], [@CR17], [@CR19]\]. Two studies had assessed *AMELX* rs6639060 in 157 cases and 144 controls \[[@CR13], [@CR21]\], and two studies had assessed *AMELX* rs2106416 in 175 cases and 110 controls \[[@CR13], [@CR18]\]. One study \[[@CR18]\] included two subsets. The genotyping method in all studies was based on polymerase chain reaction (PCR). The controls in six studies \[[@CR11], [@CR17], [@CR18], [@CR21]--[@CR23]\] had low/very low rate of dental caries and others were caries-free. In addition, the two groups in the studies were introduced as the caries group versus the caries-free group, or the high-caries group versus the low/very low caries group. Table 1Characteristics of the studies included in this meta-analysisFirst author, publication yearCountryEthnicityMean age, years (Case/ Control)Age group of individualsGenotyping methodDMFT score (Case/Control)PolymorphismsOuryouji, 2008 \[[@CR13]\]JapanAsian5.4/4.8ChildrenPCR-RFLP≥10/0*ENAM* rs3796703*AMELX* rs6639060*AMELX* rs2106416Azevedo, 2010 \[[@CR16]\]BrazilCaucasian12ChildrenPCR-SSCP≥1/0*LTF* rs1126478Kang, 2011^a^ \[[@CR17]\]KoreaAsian21.3/23.2AdultsPCR\> 2/≤2*AMELX* rs17878486Olszowski, 2012^ab^ \[[@CR18]\]PolandCaucasian5ChildrenPCR-RFLP≥3/\< 3*AMELX* rs210641613ChildrenPCR-RFLP≥3/\< 3*AMELX* rs2106416Gasse, 2013 \[[@CR12]\]FranceCaucasian7.6/22BothPCR≥4/0*AMELX* rs946252Jeremias, 2013^a^ \[[@CR11]\]BrazilMixedCase: \< 6Control: \< 20ChildrenRT-PCR≥4/≤3*ENAM* rs1264848*ENAM* rs3796704*AMELX* rs946252*AMELX* rs17878486Ergöz, 2014 \[[@CR19]\]TurkeyCaucasian8.7/8.7ChildrenTaqMan≥1/0*ENAM* rs1264848*ENAM* rs3796704*AMELX* rs946252*AMELX* rs17878486Volckova, 2014 \[[@CR20]\]CzechCaucasianRange: 11--13ChildrenPCR-RFLP≥1/0*LTF* rs1126478Gerreth, 2016 \[[@CR14]\]PolandCaucasian2.6ChildrenRT-PCR≥1/0*ENAM* rs1264848Yildiz, 2016^a^ \[[@CR21]\]TurkeyCaucasianRange: 20--60AdultsPCR-RFLP≥14/≤5*AMELX* rs6639060Gerreth, 2017 \[[@CR15]\]PolandCaucasianRange: 1.7--3.5ChildrenTaqMan≥1/0*AMELX* rs17878486Wang, 2017 \[[@CR5]\]ChinaAsian3.5/3.7ChildrenPCR≥4/0*LTF* rs1126478*ENAM* rs3796703Borilova Linhartova, 2018^a^ \[[@CR22]\]CzechCaucasianRange: 13--15ChildrenTaqMan≥1/0*ENAM* rs1264848Koohpeima, 2018^a^ \[[@CR23]\]IranCaucasian29.8/28.4AdultsARMS-PCRNA*ENAM* rs3796704Wang, 2018 \[[@CR24]\]ChinaAsianRange: 2--4ChildrenPCR≥8/0*LTF* rs1126478Devang Divakar, 2019 \[[@CR25]\]Saudi ArabiaCaucasian6.9/23.2BothRT-PCR≥4/0*ENAM* rs1264848*ENAM* rs3796704^a^Case group included individuals with high caries and control group included individuals with low/very low caries. ^b^ This study had two subsets: one subset was reported in 5-year-olds and another in 13-year-oldsAbbreviations: *NA* Not available, *PCR* Polymerase chain reaction, *RFLP* Restriction fragment length polymorphism, *RT* Real time, *ARMS* Amplification refractory mutation system, *LTF* Lactotransferrin, *ENAM* Enamelin; AMELX; Amelogenin X

The genotype prevalence of each polymorphism included in each study in both case and control groups and the *p*-value for the Hardy-Weinberg equilibrium (HWE) for the controls are shown in Table [2](#Tab2){ref-type="table"}. The controls in three studies \[[@CR11], [@CR12], [@CR21]\] had a deviation from the HWE (*P* \< 0.05). Table 2Prevalence of genotypes of the three polymorphisms (*LTF*, *ENAM* and *AMELX*)First author, publication year*LTF*\
rs1126478^a^*ENAM*\
s1264848^a^*ENAM*\
rs3796704^a^*ENAM* rs3796703^b^P-value of HWE for controlsCaseControlCaseControlCaseControlCaseControlOuryouji, 2008 \[[@CR13]\]NANANANANANA76/4/059/8/00.603Azevedo, 2010 \[[@CR16]\]16/30/1619/22/7NANANANANANA0.877Jeremias, 2013 \[[@CR11]\]NANA13/44/2021/41/204/11/611/19/57NANA0.999/0.676Ergöz, 2014 \[[@CR19]\]NANA4/41/551/35/640/16/781/27/69NANA0.108/0.351Volckova, 2014 \[[@CR20]\]288/150/4486/56/13NANANANANANA0.374Gerreth, 2016 \[[@CR14]\]NANA8/37/34/26/18NANANANA0.202Wang, 2017 \[[@CR5]\]64/222/21964/209/227NANANANA439/64/2458/42/00.149/0.327Borilova Linhartova, 2018 \[[@CR22]\]NANA45/259/23719/74/84NANANANA0.656Koohpeima, 2018 \[[@CR23]\]NANANANA0/32/2040/20/146NANA0.409Wang, 2018 \[[@CR24]\]63/224/22051/168/184NANANANANANA0.196Devang Divakar, 2019 \[[@CR25]\]NANA89/58/21116/68/911/58/9925/76/92NANA0.809/0.146First author, publication year*AMELX* rs946252^b^*AMELX* rs17878486^b^*AMELX* rs6639060^b^*AMELX* rs2106416^b^*P*-value of HWE for controlsCaseControlCaseControlCaseControlCaseControlOuryouji, 2008 \[[@CR13]\]NANANANA80/0/067/0/078/2/016/6/0NA/0.458Kang, 2011 \[[@CR17]\]NANA1/2/820/2/29NANANANA0.852Olszowski, 2012 (i) \[[@CR18]\]NANANANANANA24/13/021/12/10.643Olszowski, 2012 (ii) \[[@CR18]\]NANANANANANA26/26/628/20/20.495Gasse, 2013 \[[@CR12]\]5/9/254/1/25NANANANANANA**\< 0.0001**Jeremias, 2013 \[[@CR11]\]61/12/563/13/54/15/5715/11/56NANANANA**0.002/\< 0.0001**Ergöz, 2014 \[[@CR19]\]5/18/1110/17/98/18/143/21/8NANANANA0.742/0.051Yildiz, 2016 \[[@CR21]\]NANANANA54/11/1256/9/12NANA**\< 0.0001**Gerreth, 2017 \[[@CR15]\]NANA8/10/3031/14/3NANANANA0.422Abbreviations: *LTF* Lactotransferrin, *ENAM* Enamelin, *AMELX* Amelogenin X, *NA* Not available, *HWE* Hardy-Weinberg equilibrium^a^Genotypes: AA/AG/GG^b^Genotypes: CC/CT/TT. i: 5-year-olds. ii: 13-year-olds

Pooled analysis {#Sec11}
---------------

Table [3](#Tab3){ref-type="table"} shows the results of pooled analysis of each polymorphism based on five genetic models. Among the polymorphisms, only the G allele \[OR = 1.38; 95%CI: 1.08, 1.76; *P =* 0.009; I^2^ = 27% (P~heterogeneity~ or P~h~ = 0.25)\] and the GG genotype \[OR = 1.41; 95%CI: 1.06, 1.87; *P* = 0.02; I^2^ = 18, (P~h~ = 0.30)\]) of *ENAM* rs3796704 had an elevated risk in the case group compared with the control group. In addition, the funnel plots of each polymorphism are presented in the [Supplementary file](#MOESM1){ref-type="media"}. Therefore, there was a significant association between *ENAM* rs3796704 polymorphism and dental caries susceptibility. Table 3Results of pooled analysis of each polymorphism based on five genetic modelsPolymorphism, (number of studies)G vs. AGG vs. AAAG vs. AAAG + GG vs. AAGG vs. AA + AGOR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~*LTF* rs1126478 (*n* = 4)0.98 (0.87, 1.10), 0.68, 25, 0.261.03 (0.80, 1.33), 0.82, 4, 0.371.00 (0.80, 1.25), 0.99, 4, 0.440.99 (0.81, 1.23), 0.96, 7, 0.360.95 (0.80, 1.13), 0.58, 0, 0.45*ENAM* rs1264848 (*n* = 5)0.93 (0.65, 1.32), 0.68, 75, 0.0030.88 (0.34, 2.30), 0.79, 76, 0.0021.21 (0.88, 1.65), 0.24, 0, 0.481.24 (0.93, 1.67), 0.15, 24, 0.260.83 (0.44, 1.58), 0.58, 79, 0.0007*ENAM* rs3796704 (n = 4)**1.38 (1.08, 1.76), 0.009, 27, 0.25**1.86 (0.96, 3.62), 0.07, 44, 0.171.27 (0.64, 2.52), 0.49, 50, 0.131.64 (0.86, 3.14), 0.13, 43, 0.17**1.41 (1.06, 1.87), 0.02, 18, 0.30**Polymorphism, (number of studies)T vs. CTT vs. CCCT vs. CCCT + TT vs. CCTT vs. CC + CTOR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~*ENAM* rs3796703 (*n* = 2)0.92 (0.24, 3.58), 0.91, 78, 0.035.22 (0.25, 108.96), 0.290.89 (0.23, 3.48), 0.87, 77, 0.040.90 (0.23, 3.63), 0.89, 78, 0.032.90 (0.92, 9.12), 0.07, 0, 0.69*AMELX* rs946252 (*n* = 3)1.01 (0.68, 1.51), 0.95, 39, 0.201.27 (0.58, 2.75), 0.55, 0, 0.511.45 (0.75, 2.81), 0.27, 31, 0.231.21 (0.68, 2.14), 0.52, 0, 0.510.82 (0.43, 1.56), 0.54, 0.38, 0.20*AMELX* rs17878486 (n = 4)2.25 (0.81, 6.24), 0.12, 86, 0.00013.59 (0.55, 23.32), 0.18, 81, 0.0011.45 (0.36, 5.80), 0.60, 0.67, 0.032.30 (0.51, 10.33), 0.28, 77, 0.0043.10 (0.85, 11.28), 0.09, 81, 0.001*AMELX* rs6639060 (n = 2)1.08 (0.63, 1.85), 0.781.04 (0.43, 2.51), 0.941.27 (0.49, 3.30), 0.631.14 (0.56, 2.29), 0.721.00 (0.42, 2.39), 1.00*AMELX* rs2106416 (n = 3)0.59 (0.16, 2.11), 0.41, 82, 0.0031.83 (0.47, 7.06), 0.38, 40, 0.200.55 (0.13, 2.25), 0.40, 80, 0.0060.59 (0.15, 2.31), 0.45, 79, 0.0081.67 (0.44, 6.34), 0.45, 31, 0.23Abbreviations: *LTF* Lactotransferrin, *ENAM* Enamelin, *AMELX* Amelogenin X, *NA* Not available, *OR* Odds ratio, *CI* Confidence interval; P~h~, P~heterogeneity~

Subgroup analysis {#Sec12}
-----------------

Table [4](#Tab4){ref-type="table"} identifies the subgroup analyses based on the ethnicity, age group, and the control group for each polymorphism and in five genetic models. The results showed that the G allele and the GG and AG genotypes of *ENAM* rs3796704 had an elevated risk in the case group compared with the control group in the Caucasian ethnicity; whereas in studies with a caries-free control group, the G allele and GG genotype had an elevated risk in the case group compared with the control group. In addition, the T allele, and TT and CT genotypes of *AMELX* rs17878486 polymorphism had an elevated risk in the case group compared with the control group in mixed ethnicity and studies with a caries-free control group. Therefore, there was a significant association between both polymorphisms of *ENAM* rs3796704 and *AMELX* rs17878486 and dental caries susceptibility in the Caucasian ethnicity and studies including caries-free individuals as the control group. Table 4Subgroup analysis of each polymorphism based on ethnicity, age group, and control groupPolymorphism, (number of studies)G vs. AGG vs. AAAG vs. AAAG + GG vs. AAGG vs. AA + AGOR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~LTF rs1126478Ethnicity Caucasian (2)1.18 (0.66, 2.11), 0.58, 73, 0.051.49 (0.58, 3.85), 0.41, 55, 0.131.02 (0.53, 1.97), 0.95, 53, 0.141.16 (0.53, 1.97), 0.95, 0.53, 0.141.33 (0.77, 2.29), 0.30, 6, 0.30 Asian (2)0.96 (0.84, 1.09), 0.52, 0, 0.980.97 (0.73, 1.29), 0.81, 0, 0.991.07 (0.80, 1.43), 0.64, 0, 0.961.02 (0.78, 1.33), 0.91, 0, 0.970.92 (0.77, 1.10), 0.35, 0, 0.96Age group Children (4)0.98 (0.87, 1.10), 0.68, 25, 0.261.03 (0.80, 1.33), 0.82, 4, 0.371.00 (0.80, 1.25), 0.99, 4, 0.440.99 (0.81, 1.23), 0.96, 7, 0.360.95 (0.80, 1.13), 0.58, 0, 0.45Control group Caries free (4)0.98 (0.87, 1.10), 0.68, 25, 0.261.03 (0.80, 1.33), 0.82, 4, 0.371.00 (0.80, 1.25), 0.99, 4, 0.440.99 (0.81, 1.23), 0.96, 7, 0.360.95 (0.80, 1.13), 0.58, 0, 0.45ENAM rs1264848Ethnicity Caucasian (4)0.86 (0.56, 1.32), 0.49, 80, 0.0020.67 (0.18, 2.45), 0.54, 82, 0.00091.13 (0.80, 1.59), 0.48, 0, 0.451.18 (0.86, 1.62), 0.31, 35, 0.200.76 (0.34, 1.72), 0.51, 84, 0.0003 Mixed (1)1.23 (0.79,1.91), 0.361.62 (0.64, 4.09), 0.311.73 (0.77, 3.90), 0.181.69 (0.78, 3.68), 0.181.09 (0.53, 2.23), 0.82Age group Children (4)0.82 (0.57, 1.18), 0.28, 67, 0.030.58 (0.19, 1.82), 0.35, 74, 0.011.30 (0.84, 2.01), 0.26, 3, 0.361.16 (0.76, 1.75), 0.49, 42, 0.160.66 (0.37, 1.17), 0.15, 70, 0.02Control group Caries free (3)0.79 (0.39, 1.63), 0.53, 86, 0.00060.42 (0.03, 5.41), 0.51, 88, 0.00031.00 (0.66, 1.51), 1.00, 0, 0.440.74 (0.27, 2.02), 0.56, 55, 0.110.66 (0.15, 2.95), 0.59, 89, \< 0.0001 Low caries (2)1.03 (0.83, 1.29), 0.78, 0, 0.371.30 (0.79, 2.14), 0.30, 0, 0.591.57 (0.97, 2.53), 0.07, 0, 0.761.45 (0.92, 2.28), 0.11, 0, 0.620.90 (0.66, 1.23), 0.51, 0, 0.57ENAM rs3796704Ethnicity Caucasian (3)**1.43 (1.10, 1.85), 0.007, 45, 0.162.49 (1.19, 5.24), 0.02, 0, 0.85**1.74 (0.81, 3.74), 0.16, 0, 0.98**2.16 (1.05, 4.45), 0.04, 0, 0.851.41 (1.04, 1.91), 0.03, 45, 0.16** Mixed (1)1.11 (0.57, 2.15), 0.770.27 (0.03, 2.47), 0.240.14 (0.01, 1.46), 0.100.24 (0.03, 2.17), 0.201.43 (0.67, 3.05), 0.36Age group Children (2)1.46 (0.92, 2.32), 0.11, 22, 0.260.61 (0.13, 2.93), 0.54, 38, 0.200.35 (0.07, 1.74), 0.20, 35, 0.220.54 (0.11, 2.56), 0.44, 37, 0.21**1.71 (1.02, 2.85), 0.04, 0, 0.53**Control group Caries free (2)**1.62 (1.21, 2.17), 0.001, 0, 0.592.499 (1.19, 5.24), 0.02, 0, 0.85**1.74 (0.81, 3.74), 0.16, 0, 0.98**2.16 (1.05, 4.45), 0.04, 0, 0.851.67 (1.17, 2.39), 0.0050, 0.58** Low caries (2)0.97 (0.63, 1.50), 0.89, 0, 0.610.27 (0.03, 2.47), 0.240.14 (0.01, 1.46), 0.100.24 (0.03, 2.17), 0.201.05 (0.66, 1.68), 0.83, 0, 0.32Polymorphism, (number of studies)T vs. CTT vs. CCCT vs. CCCT + TT vs. CCTT vs. CC + CTOR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~OR (95%CI), *P*-value, I^2^ (%), P~h~ENAM rs3796703Ethnicity Asian (2)0.92 (0.24, 3.58), 0.91, 78, 0.035.22 (0.25, 108.96), 0.290.89 (0.23, 3.48), 0.87, 77, 0.040.90 (0.23, 3.63), 0.89, 78, 0.032.90 (0.92, 9.12), 0.07, 0, 0.69Age group Children (2)0.92 (0.24, 3.58), 0.91, 78, 0.035.22 (0.25, 108.96), 0.290.89 (0.23, 3.48), 0.87, 77, 0.040.90 (0.23, 3.63), 0.89, 78, 0.032.90 (0.92, 9.12), 0.07, 0, 0.69AMELX rs946252Ethnicity Caucasian (2)0.95 (0.35, 2.55), 0.92, 69, 0.071.42 (0.54, 3.76), 0.48, 17, 0.272.80 (0.93, 8.43), 0.07, 0, 0.381.63 (0.67, 4.01), 0.28, 0, 0.420.73 (0.19, 2.87), 0.66, 67, 0.08 Mixed (1)0.99 (0.53, 1.86), 0.981.03 (0.28, 3.75), 0.960.95 (0.40, 2.25), 0.910.98 (0.46, 2.07), 0.951.04 (0.29, 3.75), 0.95Age group Children (2)1.21 (0.77,1.91), 0.42, 0, 0.371.54 (0.61, 3.92), 0.36, 0, 0.371.24 (0.61, 2.49), 0.56, 5, 0.311.24 (0.66, 2.33), 0.50, 24, 0.251.26 (0.56, 2.83), 0.25Control group Caries free (2)0.95 (0.35, 2.55), 0.92, 69, 0.071.42 (0.54, 3.76), 0.48, 17, 0.272.80 (0.93, 8.43), 0.07, 0, 0.381.63 (0.67, 4.01), 0.28, 0, 0.420.73 (0.19, 2.87), 0.66, 67, 0.08 Low caries (1)0.99 (0.53, 1.86), 0.981.03 (0.28, 3.75), 0.960.95 (0.40, 2.25), 0.910.98 (0.46, 2.07), 0.951.04 (0.29, 3.75), 0.95AMELX rs17878486Ethnicity Caucasian (2)2.87 (0.35, 23.23), 0.32, 95, \< 0.00015.12 (0.09, 278.85), 0.42, 93, 0.00021.00 (0.12, 8.23), 1.00, 0.81, 0.022.03 (0.10, 42.44), 0.65, 92, 0.00046.17 (0.41, 92.05), 0.19, 91, 0.001 Asian (1)1.38 (0.25, 7.75), 0.710.93 (0.04, 23.52), 0.970.33 (0.01, 12.82), 0.560.89 (0.04, 22.53), 0.951.89 (0.30, 11.85), 0.50 Mixed (1)**1.87 (1.06, 3.30), 0.033.82 (1.19, 12.21), 0.025.11 (1.33, 19.72), 0.024.03 (1.27, 12.75), 0.02**1.39 (0.69, 2.80), 0.35Age group Children (3)2.48 (0.76, 8.05), 0.13, 90, \< 0.00014.69 (0.55, 40.16), 0.16, 86, 0.00071.72 (0.37, 7.92), 0.48, 75, 0.022.65 (0.49, 14.35), 0.26, 84, 0.0023.55 (0.72, 17.60), 0.12, 87, 0.0004 Adults (1)1.38 (0.25, 7.75), 0.710.93 (0.04, 23.52), 0.970.33 (0.01, 12.82), 0.560.89 (0.04, 22.53), 0.951.89 (0.30, 11.58), 0.50Control group Caries free (2)2.87 (0.35, 23.23), 0.32, 95, \< 0.00015.12 (0.09, 278.85), 0.42, 93, 0.00021.00 (0.12, 8.23), 1.00, 0.81, 0.022.03 (0.10, 42.44), 0.65, 92, 0.00046.17 (0.41, 92.05), 0.19, 91, 0.001 Low caries (2)**1.82 (1.06, 3.11), 0.03, 0, 0.743.28 (1.14, 9.43), 0.03, 0, 0.423.42 (1.04, 11.28), 0.04, 47, 0.173.43 (1.21, 9.75), 0.02, 0, 0.39**1.44 (0.75, 2.77), 0.27, 0, 0.76AMELX rs6639060Ethnicity Caucasian (1)1.08 (0.63, 1.85), 0.781.04 (0.43, 2.51), 0.941.27 (0.49,3.30), 0.631.14 (0.56, 2.29), 0.721.00 (0.42, 2.39), 1.00Age group Adults (1)1.08 (0.63, 1.85), 0.781.04 (0.43, 2.51), 0.941.27 (0.49,3.30), 0.631.14 (0.56, 2.29), 0.721.00 (0.42, 2.39), 1.00AMELX rs2106416Ethnicity Caucasian (2)1.25 (0.77, 2.03), 0.37, 30, 0.231.83 (0.47, 7.06), 0.38, 40, 0.201.20 (0.65, 2.22), 0.56, 0, 0.541.25 (0.69, 2.27), 0.46, 0, 0.351.67 (0.44, 6.34), 0.45, 31, 0.23Age group Children (3)0.59 (0.16, 2.11), 0.41, 82, 0.0031.83 (0.47, 7.06), 0.38, 40, 0.200.55 (0.13, 2.25), 0.40, 80, 0.0060.59 (0.15, 2.31), 0.45, 79, 0.0081.67 (0.44, 6.34), 0.45, 31, 0.23Abbreviations: *LTF* Lactotransferrin, *ENAM* Enamelin, *AMELX* Amelogenin X, *OR* Odds ratio, *CI* Confidence interval; P~h~, P~heterogeneity~

Sensitivity analysis {#Sec13}
--------------------

One study \[[@CR19]\] was omitted from the analysis of *AMELX* rs17878486 because the outlier data and the results illustrated that by deleting this study, the CT \[OR = 3.07; 95%CI: 1.36, 6.94; *P* = 0.007; I^2^ = 0% (P~h~ = 0.37)\] and CT + TT \[OR = 5.72; 95%CI: 2.83, 11.59; P = \< 0.00001; I^2^ = 21% (P~h~ = 0.0.28)\] genotypes in dental caries patients were significantly superior to controls and with a low heterogeneity, respectively (Table [3](#Tab3){ref-type="table"})**.** In addition, other sensitivity analyses including "one study excluded" and "cumulative analysis" were performed and the previous results did not change qualitatively. Although the genotype distribution of the controls in three studies \[[@CR11], [@CR12], [@CR21]\] did not follow the HWE, these analyses reported that the pooled ORs based on all genetic models were steady.

Publication bias {#Sec14}
----------------

Both Egger's and Begg's tests were done on the previous pooled analyses with a minimum of three studies (Fig. [2](#Fig2){ref-type="fig"}). The results revealed a publication bias regarding GG vs. AA, AG vs. AA, and AG + GG vs. AA models of *LTF* rs1126478 polymorphism (Begg's test: *P* \< 0.05) and also T vs. C and CT + TT vs. CC models of *AMELX* rs2106416 polymorphism (Begg's test: *P* \< 0.05). Fig. 2Funnel plots of the analysis of each polymorphism with a minimum of three studies**:** A) LTF rs1126478, B) ENAM s1264848, C) ENAM rs3796704, D) AMELX rs946252, E) AMELX rs17878486, and F) AMELX rs2106416

Discussion {#Sec15}
==========

The effect of environmental risk factors \[[@CR26]\] and genetic predisposition \[[@CR27]\] on development of caries has been well identified. This meta-analysis assessed the association between the common polymorphisms of *LTF*, *ENAM*, and *AMELX* and the risk of dental caries. The findings showed that *ENAM* rs3796704 polymorphism had an increased risk in the case group compared with the control group especially in the Caucasian ethnicity and studies with caries-free individuals as the control group.

The prevalence of *LTF* polymorphisms differs among various ethnicities \[[@CR28]\]. The genotypes related to LTF level are associated with decreased function and this may lead to decreased defense against infection with stronger stimuli for granulocyte activation and desorption, leading to greater LTF release \[[@CR28]\]. Four studies \[[@CR5], [@CR16], [@CR20], [@CR24]\] included in this meta-analysis assessed *LTF* rs1126478 polymorphism. However, none of them found any association between this polymorphism and dental caries susceptibility. In addition, the subgroup analysis in this meta-analysis did not find any association between this polymorphism and dental caries risk. Thus, we can exclude *LTF* rs1126478 polymorphism as a risk factor for dental caries; however, more accurate confirmation of results requires further research through larger studies on different ethnicities.

AMELX is the most significant factor for development of normal enamel \[[@CR17]\] and *AMELX* aberration predominantly causes mineralization defects and congenital disorders such as amelogenesis imperfecta \[[@CR29]\]. Therefore, some researchers suggest that genetic variations contribute to structural changes of the enamel and may create more levels of mineral loss, bacterial extension or biofilm deposition \[[@CR30]\]. In our meta-analysis on *AMELX* rs946252, *AMELX* rs17878486, *AMELX* rs6639060, and *AMELX* rs2106416 polymorphisms, none of them was associated with the risk of dental caries. However, the sensitivity analysis revealed that *AMELX* rs17878486 polymorphism could be a risk factor for dental caries but the ethnicity and type of selected controls were the effective factors on the association between *AMELX* rs17878486 polymorphism and risk of dental caries. In addition, two studies included in our meta-analysis \[[@CR11], [@CR15]\] showed an association between *AMELX* rs17878486 polymorphism and dental caries susceptibility. Therefore, it may point to the role of *AMELX* rs17878486 polymorphism in development of dental caries more than others.

*ENAM* gene may also play a role in enamel formation \[[@CR31]\] and any change in genes that encode enamel proteins may lead to enamel malformation \[[@CR32]\]. Among studies on *ENAM* polymorphisms included in this meta-analysis, one study on Saudi patients \[[@CR25]\] reported an elevated risk of *ENAM* rs1264848 polymorphism and another study on Polish children \[[@CR14]\] showed the protective role of *ENAM* rs1264848 polymorphism in dental caries, which was confirmed by Abbasoğlu et al., in their study on Turkish children \[[@CR33]\]. Also, one study \[[@CR25]\] reported an elevated risk of *ENAM* rs3796704 polymorphism and another study \[[@CR5]\] showed an elevated risk of *ENAM* rs3796703 polymorphism in dental caries patients compared with controls. One research \[[@CR22]\] reported that there were significant differences in the minor allele frequency between the Poles and Czechs populations. In addition, the sensitivity analysis confirmed the effect of ethnicity and type of control group on the association of *ENAM* rs3796704 and risk of dental caries. Bayram and colleagues \[[@CR34]\] showed that *ENAM* polymorphisms may affect the development of enamel and these effects may be different between primary and permanent dentitions.

Small number of studies included in each analysis and different DMFT scores for selecting the cases and controls between the studies were two important limitations of the present meta-analysis. However, in most analyses, the heterogeneity was low and there was no publication bias.

Conclusions {#Sec16}
===========

The findings of this meta-analysis confirmed that the G allele and the GG genotype of *ENAM* rs3796704 polymorphism were associated with an elevated risk of caries in the case group compared with the control group. But there was no association between *LTF* rs1126478, *ENAM* rs1264848, *ENAM* rs3796703, *AMELX* rs946252, *AMELX* rs17878486, and *AMELX* rs2106416 polymorphisms and dental caries susceptibility. However, subgroup analysis showed an association between *ENAM* rs3796704 and *AMELX* rs17878486 polymorphisms and dental caries susceptibility in the Caucasian ethnicity and studies including caries-free individuals as the control group. In addition, sensitivity analysis showed an increased risk of *AMELX* rs17878486 polymorphism in the case group compared with the control group. The future analyses with more cases in various areas should have focused on possible effects of gene-environmental interactions on caries experience.
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LTF

:   Lactotransferrin

ENAM

:   Enamelin

AMELX

:   Amelogenin X

OR

:   Odds ratio

HWE

:   Hardy-Weinberg equilibrium

CI

:   Confidence interval

DMFT

:   Decayed, Missing, and Filled Teeth
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